BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22214026)

  • 1. [Peptide vaccine treatment for colorectal cancer].
    Okuno K
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():574-8. PubMed ID: 22214026
    [No Abstract]   [Full Text] [Related]  

  • 2. The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma.
    Inoda S; Morita R; Hirohashi Y; Torigoe T; Asanuma H; Nakazawa E; Nakatsugawa M; Tamura Y; Kamiguchi K; Tsuruma T; Terui T; Ishitani K; Hashino S; Wang Q; Greene MI; Hasegawa T; Hirata K; Asaka M; Sato N
    Exp Mol Pathol; 2011 Feb; 90(1):55-60. PubMed ID: 20950610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [WT1 peptide-based immunotherapy for the treatment of malignancies: focusing on hematological neoplasms].
    Oka Y; Tsuboi A; Nishida S; Hosen N; Nakata J; Hashii Y; Maeda T; Oji Y; Kumanogoh A; Sugiyama H
    Rinsho Ketsueki; 2011 May; 52(5):235-42. PubMed ID: 21646768
    [No Abstract]   [Full Text] [Related]  

  • 4. Peptide-based vaccination for colorectal cancer.
    Tsuruma T; Hata F; Furuhata T; Ohmura T; Katsuramaki T; Yamaguchi K; Kimura Y; Torigoe T; Sato N; Hirata K
    Expert Opin Biol Ther; 2005 Jun; 5(6):799-807. PubMed ID: 15952910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell epitope peptide vaccines.
    Elsawa SF; Rodeberg DA; Celis E
    Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peptide-based vaccine therapy for cancer patients].
    Yamada A
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():602-7. PubMed ID: 15861717
    [No Abstract]   [Full Text] [Related]  

  • 7. Are peptide vaccines viable in combination with other cancer immunotherapies?
    Ohtake J; Sasada T
    Future Oncol; 2017 Aug; 13(18):1577-1580. PubMed ID: 28776424
    [No Abstract]   [Full Text] [Related]  

  • 8. Pemphigus: the promises of peptide immunotherapy.
    Di Bisceglie MB; Lucchese A; Crincoli V
    Immunopharmacol Immunotoxicol; 2009; 31(4):509-15. PubMed ID: 19874216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccine therapies against digestive-system cancers].
    Sakakibara M; Kanto T
    Nihon Rinsho; 2011 Sep; 69(9):1662-9. PubMed ID: 21922771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer vaccines: an update.
    Hipp JD; Hipp JA; Lyday BW; Minev BR
    In Vivo; 2000; 14(5):571-85. PubMed ID: 11125541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peptide vaccination therapy for malignant glioma].
    Yamanaka R; Itoh K
    Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CTL precursor-oriented peptide vaccine therapy for malignant glioma].
    Yajima N; Yamanaka R; Tanaka R; Shigemori M; Mine T; Itoh K
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():582-7. PubMed ID: 16201585
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progress on the study of ovarian carcinoma vaccine ].
    Peng P; Shen J
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):500-2. PubMed ID: 15347482
    [No Abstract]   [Full Text] [Related]  

  • 14. Toll-like receptor ligands energize peptide vaccines through multiple paths.
    Celis E
    Cancer Res; 2007 Sep; 67(17):7945-7. PubMed ID: 17804699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New era of tumor immunotherapy].
    Yoshitake Y; Nakatsura T; Nishimura Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():46-55. PubMed ID: 15861634
    [No Abstract]   [Full Text] [Related]  

  • 16. Current immunotherapeutic strategies in colon cancer.
    Morse M; Langer L; Starodub A; Hobeika A; Clay T; Lyerly HK
    Surg Oncol Clin N Am; 2007 Oct; 16(4):873-900, x. PubMed ID: 18022550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming doubts and other obstacles in the development of effective peptide-based therapeutic vaccines against cancer.
    Cho HI; Celis E
    Expert Rev Vaccines; 2010 Apr; 9(4):343-5. PubMed ID: 20370542
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy for colorectal cancer: potential application in an adjuvant setting.
    Kerr DJ; Midgley RS
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):132-7. PubMed ID: 11049045
    [No Abstract]   [Full Text] [Related]  

  • 19. Current concepts in immunotherapy for the treatment of colorectal cancer.
    Indar A; Maxwell-Armstrong CA; Durrant LG; Carmichael J; Scholefield JH
    J R Coll Surg Edinb; 2002 Apr; 47(2):458-74. PubMed ID: 12018689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [II.Current status of peptide vaccine for lung cancer].
    Suzuki H
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1009- 14. PubMed ID: 24151657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.